08 jun: Det bølgende hus
10 jun: Overskud i APM´s containerforretning
08-06-2012 23:47:00

J&J to Record $600 Million Charge Tied to Outstanding Lawsuits

Relateret indhold

By Ben Fox Rubin

Johnson & Johnson (JNJ) said it plans to record a special charge of roughly $600 million in its second quarter to increase its accrual for potential legal settlements, as it has faced a series of lawsuits over accusations of bribery and improper drug-marketing practices.

The company said the settlement payments stem for a series of outstanding civil cases that involve its drugs Risperdal, Invega and Natrecor, as well as nursing-home pharmacy operator Omnicare Inc. (OCR).

The health-care products company has faced lawsuits related to alleged off-label promotion of its antipsychotic treatment Risperdal, which was once J&J's top-selling drug before generic copycats hit the market, as well as legal challenges over off-label promotion of another schizophrenia treatment, Invega, and the heart-failure drug Natrecor.

Furthermore, the federal government is suing J&J, accusing it of paying kickbacks to induce Omnicare to encourage use of Risperdal and other J&J drugs.

In addition, J&J has dealt with state lawsuits regarding its promotion of Risperdal, including an Arkansas case in which the company in April was ordered to pay $1.2 billion after a jury found that J&J's past marketing of the drug violated the state's consumer-protection laws. J&J previously was ordered to pay $327 million in a South Carolina case and $258 million in Louisiana. The company is appealing all three cases.

In January, J&J agreed to settle a Texas case for $158 million.

Meanwhile, the company agreed to pay an $85 million fine in a criminal case regarding off-label marketing of Natrecor. Parallel civil litigation still hasn't been settled.

The company in April said its first-quarter earnings rose on a foreign-exchange-related gain tied to an acquisition and lower expenses.

Shares closed Friday at $62.98 and were unchanged after hours. The stock is down 4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

(END) Dow Jones Newswires

June 08, 2012 17:47 ET (21:47 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Moody's forudser indtjeningsvækst på 4-5 pct. i shippingmarkedet

18-06-2018 15:54:48
Udsigterne for det globale shippingmarked ser stabile ud for det næste års tid, vurderer kreditvurderingsinstituttet Moody's, som dog også spår forskelle i de enkelte undersegmenter. For tørlastsegmentet venter Moody's, at efterspørgslen vil overgå udbuddet med 1 pct. i 2018, mens der for containermarkedet ses en efterspørgsel, som vil være understøttet af bred makroøkonomisk vækst og handelsvækst..

Vestas-formand efter TDC-entre: Har ingen planer om at forlade Vestas

18-06-2018 12:00:37
Vestas' bestyrelsesformand siden 2012, Bert Nordberg, har ingen planer om at forlade den danske vindmølleproducent for at gøre plads til den formandspost hos TDC, som svenskeren tiltræder 1. august. Han erkender i et interview med Ritzau Finans dog, at det kan blive nødvendigt at skære ned på sine bestyrelsesposter. - Jeg overvejer det, men det er en drøftelse, jeg tager med nomineringskomitéerne ..

NKT/ABG: Falmende franske forventninger sender aktien ned

18-06-2018 09:37:04
Mandag morgen er det danske industrikabelselskab NKT røget ud af det fine selskab blandt eliteaktierne i det danske C25-indeks. Samtidig må selskabet se sin aktiekurs falde med 2,5 pct. til 191,10 kr. NKT kan nemlig skæve til den franske konkurrent Nexans, der venter en faldende indtjening i 2018, hvor driftsresultatet før af- og nedskrivninger ventes at lande på omkring 350 mio. euro, skriver Blo..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Aktier/tendens: Nye C25-medlemmer, DSV og Vestas i fokus
2
Fingerprint Cards stiger en del efter chefers aktieopkøb
3
Vestas-formand efter TDC-entre: Har ingen planer om at forlade Vestas
4
Mandagens aktier: Mærsk tyngede C25 - tre selskaber endte i plus
5
Norwegian kædes sammen med Lufthansa - aktien stiger

Relaterede aktiekurser

Johnson & Johnson 121,32 -1,1% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
19. juni 2018 08:30:36
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180613.1 - EUROWEB2 - 2018-06-19 08:30:36 - 2018-06-19 08:30:36 - 1 - Website: OKAY